Insider · CIK 0001797826

Thornberry Nancy

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001797826

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−10.8K sh	$22.85	−$247K	20,301
2026-09-02	DNLIDenali Therapeutics Inc.S Sale	Director	SSale	−615 sh	$23.74	−$14.6K	19,686
2026-06-22	SDGRSchrodinger, Inc.A Award	Director	AAward	+8,141 sh	—	—	25,388
2026-06-22	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,313
2026-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,408 sh	—	—	31,125
2026-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.2K sh	—	—	19,226
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+472 sh	—	—	2,507
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAD Disposition to Issuer	Director	DDisposition to Issuer	−398 sh	—	—	2,109
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+1,433 sh	—	—	1,433
2026-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award	Director	AAward	+398 sh	—	—	398
2025-06-18	SDGRSchrodinger, Inc.A Award	Director	AAward	+5,997 sh	—	—	17,247
2025-06-18	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,341 sh	—	—	9,341
2025-06-03	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+6,037 sh	—	—	24,717
2025-06-03	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.1K sh	—	—	18,111
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+398 sh	—	—	2,035
2025-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+1,199 sh	—	—	1,199
2024-06-18	SDGRSchrodinger, Inc.A Award	Director	AAward	+5,000 sh	—	—	11,250
2024-06-18	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,550 sh	—	—	8,550
2024-05-31	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,967 sh	—	—	18,680
2024-05-31	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.9K sh	—	—	17,901
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+501 sh	—	—	1,637
2024-05-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award	Director	AAward	+1,571 sh	—	—	1,571
2023-12-05	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+1,136 sh	—	—	1,136
2023-06-15	SDGRSchrodinger, Inc.A Award	Director	AAward	+6,250 sh	—	—	6,250
2023-06-15	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-01	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+4,216 sh	—	—	12,713
2023-06-01	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.6K sh	—	—	12,649
2023-05-22	SDGRSchrodinger, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.9K sh	$11.52	+$171K	14,850
2023-05-22	SDGRSchrodinger, Inc.S Sale	Director	SSale	−14.9K sh	$35.00	−$520K	0
2023-05-22	SDGRSchrodinger, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.9K sh	—	—	27,020
2022-08-11	SDGRSchrodinger, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,950 sh	$11.52	+$57K	4,950
2022-08-11	SDGRSchrodinger, Inc.S Sale	Director	SSale	−4,950 sh	$35.00	−$173K	0
2022-08-11	SDGRSchrodinger, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,950 sh	—	—	41,870
2022-06-15	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.9K sh	—	—	14,907
2022-06-02	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+5,986 sh	—	—	8,497
2022-06-02	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	17,959
2022-01-08	DNLIDenali Therapeutics Inc.A Award	Director	AAward	+627 sh	—	—	2,511
2021-06-17	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,736 sh	—	—	8,736
2021-01-08	DNLIDenali Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,535 sh	—	—	7,535
2021-01-08	DNLIDenali Therapeutics Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,511 sh	—	—	2,511
2020-02-10	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.9K sh	—	—	12,909

Recent filings

Accepted (ET)
Sep 44
Thornberry Nancy0001797826-26-000006
SEC(opens sec.gov)
Jun 234
Thornberry Nancy0001797826-26-000003
SEC(opens sec.gov)
Jun 54
Thornberry Nancy0001797826-26-000002
SEC(opens sec.gov)
May 54
Thornberry Nancy0000875320-26-000191
SEC(opens sec.gov)
Jun 204
Thornberry Nancy0001490978-25-000088
SEC(opens sec.gov)
Jun 54
Thornberry Nancy0001714899-25-000137
SEC(opens sec.gov)
May 54
Thornberry Nancy0000875320-25-000188
SEC(opens sec.gov)
Jun 204
Thornberry Nancy0001490978-24-000056
SEC(opens sec.gov)
Jun 44
Thornberry Nancy0001714899-24-000141
SEC(opens sec.gov)

Companies

Address

C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080